Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke-Reference-Cited by-同舟云学术

Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke

Published:2019-08-09 Issue:8 Volume:14 Page:e0220796
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Woo Ho Geol^ORCID,Chang Yoonkyung,Ryu Dong-Ryeol,Song Tae-Jin^ORCID

Funder

Ewha Womans University

This project was supported by grant from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression;TB Drueke;Kidney Int,2013

2. Suppression of aging in mice by the hormone Klotho;H Kurosu;Science,2005

3. Plasma klotho and cardiovascular disease in adults;RD Semba;J Am Geriatr Soc,2011

4. Klotho converts canonical FGF receptor into a specific receptor for FGF23;I Urakawa;Nature,2006

5. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel;Q Chang;Science,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging;Cells;2024-08-24

2. The association of platelet count, high-density lipoprotein cholesterol, and platelet/high-density lipoprotein cholesterol ratio with serum soluble Klotho;Lipids in Health and Disease;2024-08-17

3. Network Pharmacology and Transcriptomics to Explore the Pharmacological Mechanisms of 20(S)-Protopanaxatriol in the Treatment of Depression;International Journal of Molecular Sciences;2024-07-10

4. A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies;International Journal of Molecular Sciences;2023-08-23

5. Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial;Translational Neurodegeneration;2023-01-26